Gut Healing Natural Resource’s Role in Management of Celiac Disease, a Brief Review

Document Type : Review


1 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

4 Traditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

5 Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Celiac disease, also known as gluten intolerance, is an autoimmune digestive disorder in genetically susceptible individuals. Currently, a totally gluten free diet is considered as the only treatment for celiac disease, which means cutting out foods containing gluten protein from the diet completely. Strict adherence to this regimen can be challenging as several processed foods contain hidden gluten, added as flavor enhancer or texture modifier. In addition, the high cost and unavailability of gluten-free foods have led to patient's dissatisfaction. Moreover, there are celiac disease patients who have persistent symptoms despite dietary compliance. Emerging research have focused on discovering alternative non-dietary treatments for this disorder. There are herbal medicines and other natural resources with anti-inflammatory activity and valuable therapeutic effects in preventing or treating inflammatory diseases. As these are effective and affordable, several studies have focused on treating different diseases using these agents. However, there are few studies evaluating the effects and potential role of naturally derived compounds in celiac disease treatment. In this review, we gathered current information in this regard; hoping our article can serve as catalysts for researchers to pay more attention to natural therapies for celiac disease.


Main Subjects

  • Sciurti M, Fornaroli F, Gaiani F, Bonaguri C, Leandro G, Di Mario F, Luigi De' Angelis G. Genetic susceptibility and celiac disease: what role do HLA haplotypes play? Acta Biomed. 2018; 89(9-S): 17–21.
  • Sharma N, Bhatia S, Chunduri V, Kaur S, Sharma S, Kapoor P, Kumari A, Garg M. Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them. Front Nutr. 2020; 7: 1–26.
  • Fritz RD, Chen Y. Oat safety for celiac disease patients: theoretical analysis correlates adverse symptoms in clinical studies to contaminated study oats. Nutr Res. 2018; 60: 54–67.
  • Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, Kelly CP, Ahuja V, Makharia GK. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(6): 823–836.
  • Mahadov S, Green PHR. Celiac disease: a challenge for all physicians. Gastroenterol Hepatol (N Y). 2011; 7(8): 554–556.
  • Dias R, Pereira CB, Pérez-Gregorio R, Mateus N, Freitas V. Recent advances on dietary polyphenol's potential roles in celiac disease. Trends Food Sci Technol. 2020; 107(7): 213–225.
  • Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, Fasano A. Celiac disease: a comprehensive current review. BMC Med. 2019; 17(1): 1–20.
  • Taraghikhah N, Ashtari S, Asri N, Shahbazkhani B, Al-Dulaimi D, Rostami-Nejad M, Rezaei-Tavirani M, Razzaghi MR, Zali MR. An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects. BMC Gastroenterol. 2020; 20(1): 1–12.
  • Bascuñán Gamboa K, Vespa M, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr. 2017; 56: 449–459.
  • Samasca G, Lerner A, Gîrbovan A, Sur G, Lupan I, Makovicky P, Matthias T, Freeman HJ. Challenges in gluten-free diet in celiac disease: prague consensus. Eur J Clin Invest. 2017; 47(5): 394–397.
  • Farage P, Zandonadi R. The gluten-free diet: difficulties celiac disease patients have to face daily. Austin J Nutri Food Sci. 2014; 2(5): 1–8.
  • Harnett J, Myers S. Quality of life in people with ongoing symptoms of coeliac disease despite adherence to a strict gluten-free diet. Sci Rep. 2020; 10(1): 1–6.
  • Akirov A, Pinhas-Hamiel O. Co-occurrence of type 1 diabetes mellitus and celiac disease. World J Diabetes. 2015; 6(5): 707–714.
  • Zingone F, Capone P, Ciacci C. Celiac disease: alternatives to a gluten free diet. World J Gastrointest Pharmacol Ther. 2010; 1(1): 36–39.
  • Asri N, Rostami-Nejad M, Rezaei-Tavirani M, Razzaghi M, Asadzadeh-Aghdaei H, Zali MR. Novel therapeutic strategies for celiac disease. Middle East J Dig Dis. 2020; 12(4): 229–237.
  • Mintah SO, Asafo-Agyei T, Archer MA, Junior PAA, Boamah D, Kumadoh D, Appiah A, Ocloo A, Duah Boakye Y, Agyare C. Medicinal plants for treatment of prevalent diseases. In: Perveen S, Al-Taweel, A, Eds. Pharmacognosy-medicinal plants. London: IntechOpen, 2019.
  • El Mostafa SB, Maamri A. Herbal medicine in chronic diseases treatment: determinants, benefits and risks. In: Boutayeb A, Ed. Disease prevention and health promotion in developing countries. Springer, 2020.
  • Yatoo MI, Gopalakrishnan A, Saxena A, Parray OR, Tufani NA, Chakraborty S, Tiwari R, Dhama K, Iqbal HMN. Anti-inflammatory drugs and herbs with special emphasis on herbal medicines for countering inflammatory diseases and disorders, a review. Recent Pat Inflamm Allergy Drug Discov. 2018; 12(1): 39–58.
  • Gan WC, Smith L, Luca EJ, Harnett JE. The prevalence and characteristics of complementary medicine use by Australian and American adults living with gastrointestinal disorders: a systematic review. Complement Ther Med. 2018; 41: 52–60.
  • Somi MH, Bagheri M, Ghojazadeh M. Efficacy of an Iranian herbal preparation (Lax-Asab) in treating functional constipation: a randomized, placebo-controlled clinical trial. J Tradit Complement Med. 2015; 5(3): 153–156.
  • Ferretti G, Bacchetti T, Masciangelo S, Saturni L. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. Nutrients. 2012; 4(4): 243–257.
  • Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004; 96(3): 229–245.
  • Oniszczuk A, Widelska G, Wójtowicz A, Oniszczuk T, Wojtunik-Kulesza K, Dib A, Matwijczuk A. Content of phenolic compounds and antioxidant activity of new gluten-free pasta with the addition of chestnut flour. Molecules. 2019; 24(14): 1–13.
  • Ribeiro M, Sousa TD, Poeta P, Bagulho AS, Igrejas G. Review of structural features and binding capacity of polyphenols to gluten proteins and peptides in vitro: relevance to celiac disease. Antioxidants (Basel). 2020; 9(6): 1–17.
  • Ucci M, Di Tomo P, Tritschler F, Cordone VGP, Lanuti P, Bologna G, Di Silvestre S, Di Pietro N, Pipino C, Mandatori D, Formoso G, Pandolfi A. Anti-inflammatory role of carotenoids in endothelial cells derived from umbilical cord of women affected by gestational diabetes mellitus. Oxid Med Cell Longev. 2019; Article ID 8184656.
  • Kaulmann A, Bohn T. Carotenoids, inflammation, and oxidative stress, implications of cellular signaling pathways and relation to chronic disease prevention. Nutr Res. 2014; 34(11): 907–929.
  • Milani A, Basirnejad M, Shahbazi S, Bolhassani A. Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol. 2017; 174(11): 1290–1324.
  • Ward MS, Zhao DY, Bernstein PS. Macular and serum carotenoid concentrations in patients with malabsorption syndromes. J Ocul Biol Dis Infor. 2008; 1(1): 12–18.
  • De Stefano D, Maiuri MC, Simeon V, Grassia G, Soscia A, Cinelli MP, Carnuccio R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ. Eur J Pharmacol. 2007; 566(1): 192–199.
  • Emami B, Shakeri F, Ghorani V, Boskabady MH. Relaxant effect of Curcuma longa on rat tracheal smooth muscle and its possible mechanisms. Pharm Biol. 2017; 55(1): 2248–2258.
  • Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013; 39(1): 69–77.
  • He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015; 20(5): 9183–9213.
  • Shimizu K, Funamoto M, Sunagawa Y, Shimizu S, Katanasaka Y, Miyazaki Y, Wada H, Hasegawa K, Morimoto T. Anti-inflammatory action of curcumin and its use in the treatment of lifestyle-related diseases. Eur Cardiol Rev. 2019; 14(2): 117–122.
  • Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Avd Exp Med Biol. 2007; 509: 105–125.
  • Gismondi A, D’Agostino A, Di Marco G, Martínez-Labarga C, Leonini V, Rickards O, Canini A. Back to the roots: Dental calculus analysis of the first documented case of coeliac disease. Archaeol Anthropol Sci. 2020; 12: 1–10
  • Lopresti AL, Smith SJ, Rea A, Michel S. Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomized, double-blind, placebo-controlled study. BMC Complement Med Ther. 2021; 21(1): 1–17.
  • Ried K, Travica N, Dorairaj R, Sali A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res. 2020; 76: 37–51.
  • Mota MADL, Landim JSP, Targino TSS, Silva SFRD, Silva SLD, Pereira MRP. Evaluation of the anti-inflammatory and analgesic effects of green tea (Camellia sinensis) in mice. Acta Cir Bras. 2015; 30(4): 242–246.
  • Dias R, Brás NF, Fernandes I, Pérez-Gregorio M, Mateus N, Freitas V. Molecular insights on the interaction and preventive potential of epigallocatechin-3-gallate in celiac disease. Int J Biol Macromol. 2018; 112: 1029–1037.
  • Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014; 20(1): 91–99.
  • Vezza T, Rodríguez-Nogales A, Algieri F, Utrilla MP, Rodriguez-Cabezas ME, Galvez J. Flavonoids in inflammatory bowel disease: a review. Nutrients. 2016; 8(4): 1–22.
  • Van Buiten CB, Lambert JD, Elias RJ. Green tea polyphenols mitigate gliadin‐mediated inflammation and permeability in vitro. Mol Nutr Food Res. 2018; Article ID e1700879.
  • Van Buiten CB, Lambert JD, Sae-tan S, Elias RJ. Inhibition of gliadin digestion by green tea polyphenols and the potential implications for celiac disease. FASEB J. 2017; 31(S1): 974.
  • Urbańska B, Kowalska J. Comparison of the total polyphenol content and antioxidant activity of chocolate obtained from roasted and unroasted cocoa beans from different regions of the world. Antioxidants. 2019; 8(8): 1–13.
  • Galleano M, Oteiza PI, Fraga CG. Cocoa, chocolate, and cardiovascular disease. J Cardiovasc Pharmacol. 2009; 54(6): 483–490.
  • Andújar I, Recio MC, Giner RM, Ríos JL. Cocoa polyphenols and their potential benefits for human health. Oxid Med Cell Longev. 2012; Article ID
  • Kramer K, Yeboah-Awudzi M, Magazine N, King JM, Xu Z, Losso JN. Procyanidin B2 rich cocoa extracts inhibit inflammation in Caco-2 cell model of in vitro celiac disease by down-regulating interferon-gamma-or gliadin peptide 31-43-induced transglutaminase-2 and interleukin-15. J Funct Foods. 2019; 57: 112–120.
  • Plaza M, Oliveira D, Nilsson A, Turner C. Green and efficient extraction method to determine polyphenols in cocoa and cocoa products. Food Anal Methods. 2017; 10(8): 2677–2691.
  • Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopuncture. 2017; 20(3): 179–193.
  • Mohtashami R, Huseini HF, Heydari M, Amini M, Sadeqhi Z, Ghaznavi H, Mehrzadi S. Efficacy and safety of honey-based formulation of Nigella sativa seed oil in functional dyspepsia: a double blind randomized controlled clinical trial. J Ethnopharmacol. 2015; 175: 147–152.
  • Khan SA, Khan AM, Karim S, Kamal MA, Damanhouri GA, Mirza Z. Panacea seed “Nigella”: a review focusing on regenerative effects for gastric ailments. Saudi J Bio Sci. 2016; 23(4): 542–553.
  • Leong XF, Rais Mustafa M, Jaarin K. Nigella sativa and its protective role in oxidative stress and hypertension. Evid Based Complement Altern Med. 2013; Article ID 120732.
  • Al Mofleh IA, Alhaider AA, Mossa JS, Al-Sohaibani MO, Al-Yahya MA, Rafatullah S, Shaik SA. Gastroprotective effect of an aqueous suspension of black cumin Nigella sativa on necrotizing agents-induced gastric injury in experimental animals. Saudi J Gastroenterol. 2008; 14(3): 128–134.
  • Osman M. Refractory coeliac disease; role of Nigella sativa as immunomodulator. Br J Med Med Res. 2012; 2(4): 527–535.
  • Osman M, Taha BI, Al-Dubooni G, Muhamed LA. Immunomodulatory effect of Nigella sativa oil treatment in iron deficiency anemia caused by refractory coeliac disease. Res J Pharm Biol Chem Sci. 2012; 3(4): 887–895.
  • Osman M, Kutty M. Immunotherapeutic application of Nigella sativa oil in management of dermatitis herpetiformis associated with refractory coeliac disease. Res J Pharm Biol Chem Sci. 2013; 4(3): 1181–1186.
  • Manayi A, Vazirian M, Saeidnia S. Echinacea purpurea: pharmacology, phytochemistry and analysis methods. Pharmacogn Rev. 2015; 9(17): 63–72.
  • Vimalanathan S, Arnason JT, Hudson JB. Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components. Pharm Biol. 2009; 47(5): 430–435.
  • Abascal K, Yarnell E. Treatments for recurrent aphthous stomatitis. Altern Complement Ther. 2010; 16(2): 100–106.
  • Mood and leaky gut: from science fiction to scientific fact. [Accessed 2014]. Available from: anxietydepressionmental-health/mood-and-leaky-gut.
  • O'Bryan T, Lerner A. Nonresponsive celiac disease treated with a unique functional medical approach. Int J Celiac Dis. 2021; 9(2): 41–64.
  • Hill LL, Foote JC, Erickson BD, Cerniglia CE, Denny GS. Echinacea purpurea supplementation stimulates select groups of human gastrointestinal tract microbiota. J Clin Pharm Ther. 2006; 31(6): 599–604.
  • Sánchez E, Laparra J, Sanz Y. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol. 2012; 78(18): 6507–6515.
  • Karim N. Impact of dietary measures in autoimmune diseases. J Bahria Univ Med Dent Coll. 2019; 9(1): 1–2.
  • Dwita LP, Yati K, Gantini SN. The anti-inflammatory activity of Nigella sativa balm sticks. Sci Pharm. 2019; 87(1): 1–7.
  • Shende V, Hedaoo SA, Ansari MH, Bhomle P, Mahapatra DK. Re-highlighting the potential natural resources for treating or managing the ailments of gastrointestinal tract origin. In: Mahapatra DR, Aguilar CN, Haghi AK, Eds. Applied pharmaceutical practice and nutraceuticals. New York: Apple Academic Press, 2021.
  • Anheyer D, Frawley J, Koch AK, Lauche R, Langhorst J, Dobos G, Cramer H. Herbal medicines for gastrointestinal disorders in children and adolescents: a systematic review. Pediatrics. 2017; 139(6): 1–15.
  • Bahmani M, Zargaran A, Rafieian-Kopaei M. Identification of medicinal plants of Urmia for treatment of gastrointestinal disorders. Rev Bras Farmacogn. 2014; 24(4): 468–480.
  • Nazareth S, Lebwohl B, Tennyson CA, Simpson S, Greenlee H, Green PH. Dietary supplement use in patients with celiac disease in the United States. J Clin Gastroenterol. 2015; 49(7): 577–581.
  • Bükülmez A, Baş MT, Çiftci E. Evaluation of anti-COVID-19 measures taken by the parents of children with celiac disease: a cross-sectional study. Sao Paulo Med J. 2021; 139(3): 201–209.